Online citations, reference lists, and bibliographies.

Outcomes Of Stereotactic Radiosurgery Of Brain Metastases From Neuroendocrine Tumors.

Anussara Prayongrat, Randa Tao, Pamela K. Allen, Nandita Guha, Ganesh Rao, Zhongxiang Zhao, Jing Li, Paul D. Brown, Susan L. McGovern
Published 2018 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Background Stereotactic radiosurgery (SRS) is an established treatment for brain metastases, yet little is known about SRS for neuroendocrine tumors given their unique natural history. Objective To determine outcomes and toxicity from SRS in patients with brain metastases arising from neuroendocrine tumors. Methods Thirty-three patients with brain metastases from neuroendocrine tumors who underwent SRS were retrospectively reviewed. Median age was 61 years and median Karnofsky performance status was 80. Primary sites were lung (87.9%), cervix (6.1%), esophagus (3%), and prostate (3%). Ten patients (30.3%) received upfront SRS, 7 of whom had neuroendocrine tumors other than small cell lung carcinoma. Kaplan-Meier survival and Cox regression analyses were performed to determine prognostic factors for survival. Results With median follow-up after SRS of 5.3 months, local and distant brain recurrence developed in 5 patients (16.7%) and 20 patients (66.7%), respectively. Median overall survival (OS) after SRS was 6.9 months. Patients with progressive disease per Response Assessment in Neuro-Oncology-Brain Metastases (RANO-BM) criteria at 4 to 6 weeks after SRS had shorter median time to developing recurrence at a distant site in the brain and shorter OS than patients without progressive disease: 1.4 months and 3.3 months vs 11.4 months and 12 months, respectively (both P < .001). Toxicity was more likely in lesions of small cell histology than in lesions of other neuroendocrine tumor histology, 15.7% vs 3.3% (P = .021). No cases of grade 3 to 5 necrosis occurred. Conclusions SRS is an effective treatment option for patients with brain metastases from neuroendocrine tumors with excellent local control despite slightly higher toxicity rates than expected. Progressive disease at 4 to 6 weeks after SRS portends a poor prognosis.
This paper references
Brain carcinoid metastases: outcomes and prognostic factors.
Grant W. Mallory (2013)
Prophylactic cranial irradiation in extensive small-cell lung cancer.
Ben J. Slotman (2007)
Efficacy and limitations of salvage gamma knife radiosurgery for brain metastases of small-cell lung cancer after whole-brain radiotherapy
Kiyoshi Nakazaki (2012)
Radiosurgery for brain metastases: a score index for predicting prognosis.
Eduardo Weltman (2000)
Pulmonary Carcinoid Found in a Patient who Presented with Initial Symptoms of Brain Metastasis: Report of a Case
Yoshihiro Nakamura (2001)
Carcinoid and neuroendocrine tumors: building on success.
Pamela L. Kunz (2015)
Gamma knife radiosurgery for metastatic brain tumors from lung cancer: a comparison between small cell and non-small cell carcinoma.
Toru Serizawa (2002)
Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI).
Tatjana Seute (2008)
Neurologic complications of carcinoid
Roy A. Patchell (1986)
Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancer.
Sunit Harris (2012)
Radiosurgery to palliate symptoms in brain metastases from uterine cervix cancer
Sang-Bong Chung (2012)
Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases.
Gregory M. M. Videtic (2004)
Stereotactic radiosurgery for patients with brain metastases from small cell lung cancer.
Rodney E Wegner (2011)
Tumor histology predicts patterns of failure and survival in patients with brain metastases from lung cancer treated with gamma knife radiosurgery.
Jeffrey G Kuremsky (2013)
Contrasting treatment‐specific survival using double‐robust estimators
KyungMann Kim (2012)
Neuroendocrine tumors of the lung: an update.
Natasha Rekhtman (2010)
Response assessment criteria for brain metastases: proposal from the RANO group.
Nancy U. Lin (2015)
Upfront stereotactic radiosurgery in patients with brain metastases from small cell lung cancer: retrospective analysis of 41 patients
Shoji Yomo (2014)
Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.
R. Grandhi (2012)
Carcinoid metastasis to the brain.
R. Hlatký (2004)
Cerebral metastases: value of reirradiation in selected patients.
J. Cooper (1990)
Outcomes after whole brain reirradiation in patients with brain metastases.
Christina H. Son (2012)
Value of whole brain re-irradiation for brain metastases--single centre experience.
Evgeny Sadikov (2007)
Clinical and therapeutic aspects of extrapulmonary small cell carcinoma.
Annemiek M E Walenkamp (2009)
Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.
P. Sperduto (2010)
Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients.
Rodrigo Arriagada (2002)
Single Brain Metastases of Carcinoid Tumors
F. Maiuri (2004)
Prophylactic cranial irradiation for patients with small-cell lung cancer: a systematic review of the literature with meta-analysis
Wenwen Zhang (2013)
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.
A. Aupérin (1999)
Challenges in the diagnosis and management of cervical neuroendocrine carcinoma
Jennifer Kelly Burzawa (2015)
Neurologic disorders in 432 consecutive patients with small cell lung carcinoma.
T. Seute (2004)
The Pathologic Classification of Neuroendocrine Tumors: A Review of Nomenclature, Grading, and Staging Systems
David S Klimstra (2010)
Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study.
P. Postmus (1998)
Brain metastases: results and effects of re-irradiation.
Mark B. Hazuka (1988)
ENETS Consensus Guidelines for the Management of Brain, Cardiac and Ovarian Metastases from Neuroendocrine Tumors
M. Pavel (2010)
Nonparametric Estimation from Incomplete Observations
E. L. Kaplan (1958)
The role of radiosurgery in patients with brain metastasis from small cell lung carcinoma.
K. Jo (2011)
Comparison of the Effectiveness of “Late” and “Early” Prophylactic Cranial Irradiation in Patients with Limited-Stage Small Cell Lung Cancer
beAtA sAs-korczynskA (2010)
Analysis of outcome in patients reirradiated for brain metastases.
William W. Wong (1995)
Clinical outcomes of reirradiation of brain metastases from small cell lung cancer with Cyberknife stereotactic radiosurgery.
Adam C. Olson (2012)
Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients
Shoji Yomo (2015)
A metastatic pituitary carcinoid tumor successfully treated with gamma knife radiosurgery.
Michael C Huang (1984)
Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors.
Jason P. Sheehan (2005)

Semantic Scholar Logo Some data provided by SemanticScholar